- Home
- PCVX vs BRKR Comparison
PCVX vs BRKR Comparison
Compare PCVX & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | BRKR |
|---|---|---|
| Founded | 2013 | 1960 |
| Country | United States | United States |
| Employees | 507 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 5.6B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PCVX | BRKR |
|---|---|---|
| Price | $59.63 | $36.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $98.33 | $48.92 |
| AVG Volume (30 Days) | 1.1M | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | N/A | $6.27 |
| Revenue Next Year | N/A | $3.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.09 | $28.53 |
| 52 Week High | $65.00 | $56.22 |
Technical Indicators
Market Signals| Indicator | PCVX | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 50.48 |
| Support Level | $42.30 | $35.45 |
| Resistance Level | $65.00 | $37.32 |
| Average True Range (ATR) | 2.13 | 1.59 |
| MACD | 0.40 | 0.55 |
| Stochastic Oscillator | 91.30 | 78.81 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.